Cenomed Co-Awarded Grant to Evaluate the Use of Novel Compounds to Enhance the Effectiveness of Nerve Agent Treatments

Cenomed BioSciences, LLC, a majority-owned subsidiary of Abraxis BioScience, Inc. announced that in collaboration with co-investigators Major David Watson (Air Force Research Laboratory, Wright-Patterson Air Force Base) and Dr. James Lucot (Associate Professor of Pharmacology and Toxicology, Wright State University), it has received a three-year research and development grant from the Defense Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)/Threat Reduction Agency (DTRA).
Business Wire